ISR Immune System Regulation Holding AB (publ) reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was SEK 78.62 million compared to SEK 31.08 million a year ago.
ISR Immune System Regulation Holding AB (publ)
Equities
ISR
SE0008212195
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |